Addition of the anti-TIGIT monoclonal antibody tiragolumab to standard first-line treatment resulted in better response rates ...

Beware of fake cancer drugs that have found their way into the booming online business of counterfeit prescription ...

The role of TIGIT as a target for immuno-oncology therapies has been called into question again after it was revealed that Novartis handed back rights to a drug partnered with China’s BeiGene.

The TIGIT checkpoint has gained much attention in recent years due to the number of roles it plays in several malignancies. TIGIT’s diverse function in multiple cell types has made it a ...

随着默沙东的退出，TIGIT靶点迎来了至暗时刻。 12月16日，默沙东在其官网宣布，正式终止TIGIT单抗 Vibostolimab的临床开发项目。早在今年8月8日 ...

Multiple TIGIT clinical data readouts anticipated throughout 2025, including >400 patients from two Phase 2 trials and one Phase 1/2 assessing belrestotug + dostarlimab in 1L NSCLC and 1L HNSCC - ...

Teos Therapeutics (ITOS) outlined business updates and strategic priorities for 2025. “As iTeos enters 2025, we are well-positioned to emerge ...

I will focus on the programs which do have data. TIGIT (T-cell immunoreceptor with immunoglobulin and ITIM domains) is an inhibitory immune checkpoint receptor. Inhibiting TIGIT may enhance anti ...

1月3日，药物临床试验登记与信息公示平台官网显示，阿斯利康(AZN.US)登记了一项 Rilvegostomig 或帕博利珠单抗联合化疗一线治疗转移性非鳞状非小细胞 ...

On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test.

智通财经APP获悉，1月3日，药物临床试验登记与信息公示平台官网显示，阿斯利康(AZN.US)登记了一项 Rilvegostomig 或帕博利珠单抗联合化疗一线治疗转移 ...